Diagnostic Ability of Endoscopic Bile Cytology Using a Newly Designed Biliary Scraper for Biliary Strictures.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
01 2019
Historique:
received: 15 02 2018
accepted: 18 07 2018
pubmed: 25 7 2018
medline: 5 2 2019
entrez: 25 7 2018
Statut: ppublish

Résumé

A new device with metallic wires for scrape cytology was developed. To compare the diagnostic performance of scrape cytology and conventional cytology during endoscopic retrograde cholangiopancreatography for biliary strictures. A total of 420 cases with biliary stricture underwent transpapillary bile cytology. Among them, there are 79 cases with scrape cytology using the new device (scrape group) and 341 cases with conventional cytology (control group). Seventy-two and 174 cases underwent biliary biopsy at the same time as bile cytology in the scrape and control group, respectively. The sensitivity for malignancy of bile cytology in the scrape and control group was 41.2% [pancreatic cancer (PC): 23.1%, biliary cancer (BC): 52.5%] and 27.1% (PC: 16.3%, BC: 38.0%), respectively (P = 0.023). When analyzed PC and BC, respectively, there was no significant difference between the two groups. In the both groups, the sensitivity was significantly higher for BC than PC. In the scrape group, there was no difference in the sensitivity between cytology and biopsy [39.7% (PC: 17.4%, BC: 55.3%)], but in the control group, a significantly lower sensitivity was observed with cytology than biopsy (36.4% (PC: 19.7%, BC: 50.0%)) (P = 0.046). When analyzed PC and BC, respectively, there was no significant difference between cytology and biopsy. The sensitivity of combined cytology and biopsy was 55.6% (PC: 30.4%, BC: 71.1%) in the scrape group and 47.0% (PC: 24.6%, BC: 64.3%) in the control group. Scrape bile cytology for biliary strictures may be superior to conventional cytology.

Sections du résumé

BACKGROUND
A new device with metallic wires for scrape cytology was developed.
AIMS
To compare the diagnostic performance of scrape cytology and conventional cytology during endoscopic retrograde cholangiopancreatography for biliary strictures.
METHODS
A total of 420 cases with biliary stricture underwent transpapillary bile cytology. Among them, there are 79 cases with scrape cytology using the new device (scrape group) and 341 cases with conventional cytology (control group). Seventy-two and 174 cases underwent biliary biopsy at the same time as bile cytology in the scrape and control group, respectively.
RESULTS
The sensitivity for malignancy of bile cytology in the scrape and control group was 41.2% [pancreatic cancer (PC): 23.1%, biliary cancer (BC): 52.5%] and 27.1% (PC: 16.3%, BC: 38.0%), respectively (P = 0.023). When analyzed PC and BC, respectively, there was no significant difference between the two groups. In the both groups, the sensitivity was significantly higher for BC than PC. In the scrape group, there was no difference in the sensitivity between cytology and biopsy [39.7% (PC: 17.4%, BC: 55.3%)], but in the control group, a significantly lower sensitivity was observed with cytology than biopsy (36.4% (PC: 19.7%, BC: 50.0%)) (P = 0.046). When analyzed PC and BC, respectively, there was no significant difference between cytology and biopsy. The sensitivity of combined cytology and biopsy was 55.6% (PC: 30.4%, BC: 71.1%) in the scrape group and 47.0% (PC: 24.6%, BC: 64.3%) in the control group.
CONCLUSION
Scrape bile cytology for biliary strictures may be superior to conventional cytology.

Identifiants

pubmed: 30039240
doi: 10.1007/s10620-018-5217-y
pii: 10.1007/s10620-018-5217-y
doi:

Substances chimiques

Metals 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-248

Commentaires et corrections

Type : CommentIn

Références

Gastrointest Endosc. 2012 Feb;75(2):347-53
pubmed: 22248602
Endoscopy. 1999 Nov;31(9):712-7
pubmed: 10604612
Br J Surg. 2011 May;98(5):704-9
pubmed: 21290384
World J Gastroenterol. 2008 Feb 21;14(7):1097-101
pubmed: 18286693
Gastrointest Endosc. 2002 Nov;56(5):720-30
pubmed: 12397282
Dig Dis Sci. 2014 Sep;59(9):2314-9
pubmed: 24748227
Gastrointest Endosc. 2016 Jun;83(6):1228-35
pubmed: 26684604
Gut. 1992 Oct;33(10):1408-11
pubmed: 1446870
Scand J Gastroenterol. 1997 Apr;32(4):363-8
pubmed: 9140159
J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):211-5
pubmed: 20931342
Gastrointest Endosc. 2012 Feb;75(2):319-31
pubmed: 22248600
Am J Gastroenterol. 1995 May;90(5):722-6
pubmed: 7733076
Am J Gastroenterol. 1993 Oct;88(10):1700-4
pubmed: 8213710
Gastrointest Endosc. 1995 Dec;42(6):520-6
pubmed: 8674921
J Gastroenterol Hepatol. 2008 Oct;23(10):1501-4
pubmed: 18028351
J Gastroenterol Hepatol. 2007 Oct;22(10):1615-20
pubmed: 17573833
Am J Gastroenterol. 2004 Aug;99(8):1464-9
pubmed: 15307861
Gastrointest Endosc. 1995 Dec;42(6):565-72
pubmed: 8674929
Pancreas. 2013 Jan;42(1):20-6
pubmed: 23254913
BMC Gastroenterol. 2016 Aug 31;16:108
pubmed: 27580856
Pancreatology. 2013 May-Jun;13(3):298-304
pubmed: 23719604
Dig Endosc. 2012 May;24 Suppl 1:22-7
pubmed: 22533747
Am J Gastroenterol. 2004 Sep;99(9):1675-81
pubmed: 15330900
Am J Gastroenterol. 1996 Mar;91(3):465-7
pubmed: 8633492
Gastrointest Endosc. 1994 Mar-Apr;40(2 Pt 1):140-5
pubmed: 8013810
Gut. 1991 Oct;32(10):1188-91
pubmed: 1659552
Hepatology. 1993 Dec;18(6):1399-403
pubmed: 8244264
J Cancer Res Clin Oncol. 2012 Sep;138(9):1433-41
pubmed: 22752601
Gastrointest Endosc. 2000 Apr;51(4 Pt 1):383-90
pubmed: 10744806
Gut. 1997 May;40(5):671-7
pubmed: 9203949
Am J Gastroenterol. 1991 May;86(5):577-80
pubmed: 2028947
Gastrointest Endosc. 2017 Feb;85(2):371-379
pubmed: 27497604

Auteurs

Kazunari Nakahara (K)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan. nakahara@marianna-u.ac.jp.

Yosuke Michikawa (Y)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Ryo Morita (R)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Keigo Suetani (K)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Nozomi Morita (N)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Junya Sato (J)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Kensuke Tsuji (K)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Hiroki Ikeda (H)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Kotaro Matsunaga (K)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Tsunamasa Watanabe (T)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Nobuyuki Matsumoto (N)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Shinjiro Kobayashi (S)

Department of Gastroenterogical and General Surgery, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Takehito Otsubo (T)

Department of Gastroenterogical and General Surgery, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Fumio Itoh (F)

Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH